To evaluate the safety and efficacy of BLU-222 therapy in patients with advanced solid tumors.
COM_RESEARCHSTUDIES_DETAIL_HEADER_BASIC_CONTACT_4
North Carolina (Statewide)
Yara Abdou
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Breast)
23-1605